Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery
Keywords:
butenafine hydrochloride, fungal infection, proniosomes, slurry method, in-vitro diffusion studies, antifungal activity
Abstract
The present proniosomal gel investigation was aimed to minimize the adverse effects associated with present topical butenafine hydrochloride formulations and made to enhance its bioavailability and sustained release by novel proniosomal drug delivery system Butenafine hydrochloride is an allylamine class of advanced antifungal drug Which mainly recommended to treat long term topical fungal infection Proniosomes were prepared by slurry method using different concentrations of non-ionic surfactant span and tween and evaluated various parameter like surface morphology entrapment efficiency drug content viscosity drug content in-vitro drug release in-vitro fungal activity and stability studies The results showed that formulation F3 containing span 60 cholesterol 1 2 showed highest drug content 99 13 and entrapment efficiency 79 87 compared to other formulations The pH and viscosity of prepared all proniosomal gel formulation were found in range 5 40-6 11 and 8920-14400CPs correspondingly
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2020-03-15
Issue
Section
License
Copyright (c) 2020 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.